These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 10937947)

  • 1. Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation.
    Rouet-Benzineb P; Buhler JM; Dreyfus P; Delcourt A; Dorent R; Perennec J; Crozatier B; Harf A; Lafuma C
    Eur J Heart Fail; 1999 Dec; 1(4):337-52. PubMed ID: 10937947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
    Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG
    Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of matrix metalloproteinase expression and left ventricular function in idiopathic dilated cardiomyopathy.
    Yokoseki O; Yazaki Y; Suzuki J; Imamura H; Takenaka H; Isobe M
    Jpn Circ J; 2000 May; 64(5):352-7. PubMed ID: 10834450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of extracellular matrix remodelling are differentially expressed in paediatric and adult dilated cardiomyopathy.
    Hsia TY; Ringewald JM; Stroud RE; Forbus GA; Bradley SM; Chung WK; Spinale FG
    Eur J Heart Fail; 2011 Mar; 13(3):271-7. PubMed ID: 21147820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential gene expression of extracellular matrix components in dilated cardiomyopathy.
    Tyagi SC; Kumar S; Voelker DJ; Reddy HK; Janicki JS; Curtis JJ
    J Cell Biochem; 1996 Nov; 63(2):185-98. PubMed ID: 8913870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles.
    Polyakova V; Loeffler I; Hein S; Miyagawa S; Piotrowska I; Dammer S; Risteli J; Schaper J; Kostin S
    Int J Cardiol; 2011 Aug; 151(1):18-33. PubMed ID: 20546954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling.
    Wei Y; Cui C; Lainscak M; Zhang X; Li J; Huang J; Zhang H; Zheng Z; Hu S
    J Cell Mol Med; 2011 Apr; 15(4):773-82. PubMed ID: 20219015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis.
    Cheung C; Luo H; Yanagawa B; Leong HS; Samarasekera D; Lai JC; Suarez A; Zhang J; McManus BM
    Cardiovasc Pathol; 2006; 15(2):63-74. PubMed ID: 16533694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix Metalloproteinase 2 and 9 Enzymatic Activities are Selectively Increased in the Myocardium of Chronic Chagas Disease Cardiomyopathy Patients: Role of TIMPs.
    Baron MA; Ferreira LRP; Teixeira PC; Moretti AIS; Santos RHB; Frade AF; Kuramoto A; Debbas V; Benvenuti LA; Gaiotto FA; Bacal F; Pomerantzeff P; Chevillard C; Kalil J; Cunha-Neto E
    Front Cell Infect Microbiol; 2022; 12():836242. PubMed ID: 35372112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices.
    Li YY; Feng Y; McTiernan CF; Pei W; Moravec CS; Wang P; Rosenblum W; Kormos RL; Feldman AM
    Circulation; 2001 Sep; 104(10):1147-52. PubMed ID: 11535571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
    Hu J; Zhang X; Nothnick WB; Spencer TE
    Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of MMPs and TIMPs in moderate and severe heart failure in a transgenic model.
    Mori S; Gibson G; McTiernan CF
    J Card Fail; 2006 May; 12(4):314-25. PubMed ID: 16679266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cardiac mRNA expression of matrix metalloproteinase-1 (MMP-1) and its inhibitor (TIMP-1) in DCM patients.
    Picard F; Brehm M; Fassbach M; Pelzer B; Scheuring S; Küry P; Strauer BE; Schwartzkopff B
    Clin Res Cardiol; 2006 May; 95(5):261-9. PubMed ID: 16598395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
    Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
    Lu J; Hao J; Du H; Xiao B; Li Y; Yang X; Cui W
    Cell Physiol Biochem; 2016; 39(1):47-60. PubMed ID: 27322513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinases, their inhibitors, and lysyl oxidase in myocardial samples from dogs with end-stage systemic and cardiac diseases.
    Fonfara S; Hetzel U; Tew SR; Cripps P; Dukes-McEwan J; Clegg PD
    Am J Vet Res; 2013 Feb; 74(2):216-23. PubMed ID: 23363345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts.
    Tyagi SC; Campbell SE; Reddy HK; Tjahja E; Voelker DJ
    Mol Cell Biochem; 1996 Feb; 155(1):13-21. PubMed ID: 8717434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of gelatinases (MMP-2 and MMP-9) and tissue inhibitors of metalloproteinases (TIMP-2 and TIMP-3) in the chicken ovary in relation to follicle development and atresia.
    Hrabia A; Wolak D; Kwaśniewska M; Kieronska A; Socha JK; Sechman A
    Theriogenology; 2019 Feb; 125():268-276. PubMed ID: 30481606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support.
    Felkin LE; Birks EJ; George R; Wong S; Khaghani A; Yacoub MH; Barton PJ
    J Heart Lung Transplant; 2006 Dec; 25(12):1413-9. PubMed ID: 17178334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
    Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
    Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.